Juvenile idiopathic arthritis: A chronic pediatric musculoskeletal condition with significant orofacial manifestations

Journal of the Canadian Dental Association

Volumn 74, Issue 9, 2008, Pages 813-821

  Barr, Torin ^a   Carmichael, Nicole M ^f   Sándor, George K B ^a,b,c,d,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOLLAND BLOORVIEW KIDS REHABILITATION HOSPITAL   (Canada)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d UNIVERSITY OF OULU   (Finland)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ARTICLE; CHILD; CHRONIC DISEASE; CLASSIFICATION; DENTAL CARE; DENTAL CARIES; DIFFERENTIAL DIAGNOSIS; FACIES; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MALOCCLUSION; RETROGNATHIA; TEMPOROMANDIBULAR JOINT DISORDER;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHRONIC DISEASE; DENTAL CARE FOR CHRONICALLY ILL; DENTAL CARIES; DIAGNOSIS, DIFFERENTIAL; FACIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALOCCLUSION; METHOTREXATE; RETROGNATHISM; TEMPOROMANDIBULAR JOINT DISORDERS;

EID: 55849100720     PISSN: 07098936     EISSN: 14882159     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Jordan A, McDonagh JE. Juvenile idiopathic arthritis: the paediatric perspective. Pediatr Radiol 2006; 36(8):734-42. Epub 2006 May 4.
2. Hashkes PJ, Laxer RM. Medical treatment of juvenile idiopathic arthritis. JAMA 2005; 294(13):1671-84.
3. Johnson K, Gardner-Medwin J. Childhood arthritis: classification and radiology. Clin Radiol 2002; 57(1):47-58.
4. Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet 2007; 369(9563):767-78.
5. Murray KJ, Luyrink L, Grom AA, Passo MH, Emery H, Witte D, and others. Immunohistological characteristics of T cell infiltrates in different forms of childhood onset chronic arthritis. J Rheumatol 1996; 23(12):2116-24.
6. Gattorno M, Prigione I, Morandi F, Gregorio A, Chiesa S, Ferlito F, and others. Phenotypic and functional characterization of CCR7+ and CCR7-CD4+ memory T cells homing to the joints in juvenile idiopathic arthritis. Arthritis Res Ther 2005; 7(2):R256-67. Epub 2005 Jan 12.
7. Murray KJ, Grom AA, Thompson SD, Lieuwen D, Passo MH, Glass DN. Contrasting cytokine profiles in the synovium of different forms of juvenile rheumatoid arthritis and juvenile spondyloarthropathy: prominence of interleukin 4 in restricted disease. J Rheumatol 1998; 25(7):1388-98.
8. De Benedetti F, Ravelli A, Martini A. Cytokines in juvenile rheumatoid arthritis. Curr Opin Rheumatol 1997; 9(5):428-33.
9. Scola MP, Imagawa T, Boivin GP, Giannini EH, Glass DN, Hirsch R, and other. Expression of angiogenic factors in juvenile rheumatoid arthritis: correlation with revascularization of human synovium engrafted into SCID mice. Arthritis Rheum 2001; 44(4):794-801.
10. Gattorno M, Gregorio A, Ferlito F, Gerloni V, Parafioriti A, Felici E, and other. Synovial expression of osteopontin correlates with angiogenesis in juvenile idiopathic arthritis. Rheumatology (Oxford) 2004; 43(9):1091-6. Epub 2004 Jun 15.
11. Gattorno M, Gerloni V, Morando A, Comanducci F, Buoncompagni A, Picco P, and others. Synovial membrane expression of matrix metalloproteinases and tissue inhibitor 1 in juvenile idiopathic arthritides. J Rheumatol 2002; 29(8):1774-9.
12. Ilowite NT. Current treatment of juvenile rheumatoid arthritis. Pediatrics 2002; 109(1):109-15.
13. Hashkes PJ. Laxer RM. Medical treatment of juvenile idiopathic arthritis. JAMA 2005; 294(13):1671-84.
14. Wallace CA. Current management of juvenile idiopathic arthritis. Best Pract Res Clin Rheumatol 2006; 20(2):279-300.
15. Lam DK, Sándor GK, Holmes HI, Evans AW, Clokie CM. A review of bisphosphonate-associated osteonecrosis of the jaws and its management. J Can Dent Assoc 2007; 73(5):417-22.
16. Wallace CA. The use of methotrexate in childhood rheumatic diseases. Arthritis Rheum 1998; 41(3):381-91.
17. Ravelli A, Martini A. Methotrexate in juvenile idiopathic arthritis: answers and questions. J Rheumatol 2000; 27(8):1830-3.
18. Hunt PG, Rose CD, McIlvain-Simpson G, Tejani S. The effects of daily intake of folic acid on the efficacy of methotrexate therapy in children with juvenile rheumatoid arthritis. A controlled study. J Rheumatol 1997; 24(11):2230-2.
19. Ravelli A, Migliavacca D, Viola S, Ruperto N, Pistorio A, Martini A. Efficacy of folinic acid in reducing methotrexate toxicity in juvenile idiopathic arthritis. Clin Exp Rheumol 1999; 17(5):625-7.
20. Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, and others. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med 2000; 342(11):763-9.
21. Dekker L, Armbrust W, Rademaker CM, Prakken B, Kuis W, Wulffraat NM. Safety of anti-TNF alpha therapy in children with juvenile idiopathic arthritis. Clin Exp Rheumatol 2004; 22(2):252-8.
22. Armbrust W, Kamphuis SS, Wolfs TW, Fiselier TJ, Nikkels PG, Kuis W, and other. Tuberculosis in a nine-year old girl treated with infliximab for systemic juvenile idiopathic arthritis. Rheumatology (Oxford) 2004; 43(4):527-9.
23. Mouy R, Stephan JL, Pillet P, Haddad E, Hubert P, Prieur AM. Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases. J Pediatr 1996; 129(5):750-4.
24. Ravelli A. De Benedetti F, Viola S, Martini A. Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine. J Pediatr 1996; 128(2):275-8.
25. Cassidy JT, Petty RE, Laxer RM. Systemic connective tissue disease. In: Textbook of pediatric rheumatology, 5th edition. Philadelphia: Elsevier; 2005. p. 414-21.
26. Szer IS, Kimura Y, Malleson PN. Disease evaluation. In: Arthritis in children and adolescents. New York: Oxford University Press; 2006. p. 342-57.
27. Ravelli A. Martini A. Early predictors of outcome in juvenile idiopathic arthritis. Clin Exp Rheumatol 2003; 21(5 Suppl 31):S89-S93.
28. Lomater C, Gerloni V, Gattinara M, Mazzotti J, Cimaz R, Fantini F. Systemic onset juvenile idiopathic arthritis: a retrospective study of 80 consecutive patients followed for 10 years. J Rheumatol 2000; 27(2):491-6.
29. Singh-Grewal D, Schneider R, Bayer N, Feldman BM. Predictors of disease course and remission in systemic juvenile idiopathic arthritis: significance of early clinical and laboratory features. Arthritis Rheum 2006; 54(5):1595-601.
30. Guillaume S, Prieur AM, Caste J, Job-Deslandre C. Long-term outcome and prognosis in oligoarticular-onset juvenile idiopathic arthritis. Arthritis Rheum 2000; 43(8):1858-65.
31. Oen K, Malleson PN, Cabral DA, Rosenberg AM, Petty RE, Cheang M. Disease course and outcome of juvenile rheumatoid arthritis in a multicentre cohort. J Rheumatol 2002; 29(9):1989-99.
32. Simon D, Fernando C, Czernichow P, Prieur AM. Linear growth and final height in patients with systemic juvenile idiopathic arthritis treated with long-term glucocorticoids. J Rheumatol 2002; 29(6):1296-300.
33. Liem JJ, Rosenberg AM. Growth patterns in juvenile rheumatoid arthritis. Clin Exp Rheumatol 2003; 21(5):663-8.
34. Lien G, Flatø B, Haugen M, Vinje O, Sørskaar D, Dale K, and others. Frequency of osteopenia in adolescents with early-onset juvenile idiopathic arthritis: a long-term outcome study of one hundred five patients. Arthritis Rheum 2003; 48(8):2214-23.
35. Welbury RR, Thomason JM, Fitzgerald JL, Steen IN, Marshall NJ, Foster HE. Increased prevalence of dental caries and poor oral hygiene in juvenile idiopathic arthritis. Rheumatology (Oxford) 2003; 42(12):1445-51. Epub 2003 Jun 16.
36. Walton AG, Welbury RR, Thomason JM, Foster HE. Oral health and juvenile idiopathic arthritis: a review. Rheumatology (Oxford) 2000; 39(5):550-5.
37. Maguire A, Rugg-Gunn AJ. Consumption of prescribed and over-the-counter (OTC) liquid oral medicines (LOMs) in Great Britain and the northern region of England, with special regard to sugar content. Public Health 1994; 108(2):121-30.
38. Twilt M, Schulten AJ, Nicolaas P, Dülger A, van Suijlekom-Smit LW. Facioskeletal changes in children with juvenile idiopathic arthritis. Ann Rheum Dis 2006; 65(6):823-5.
39. Arabshahi B, Cron RQ. Temporomandibular joint arthritis in juvenile idiopathic arthritis: the forgotten joint. Curr Opin Rheumatol 2006; 18(5):490-5.
40. Foster HE, Eltringham MS, Kay LJ, Friswell M, Abinun M, Myers A. Delay in access to appropriate care for children presenting with musculoskeletal symptoms and ultimately diagnosed with juvenile idiopathic arthritis. Arthritis Rheum 2007; 57(6):921-7.
41. Ince DO, Ince A, Moore TL. Effect of methotrexate on the temporomandibular joint and facial morphology in juvenile rheumatoid arthritis patients. Am J Orthod Dentofacial Orthop 2000; 118(1):75-83.
42. Sidiropoulou-Chatzigianni S, Papadopoulos MA, Kolokithas G. Dentoskeletal morphology in children with juvenile idiopathic arthritis compared with healthy children. J Orthod 2001; 28(1):53-8.
43. Ueeck BA, Mahmud NA, Myall RW. Dealing with the effects of juvenile rheumatoid arthritis in growing children. Oral Maxillofac Surg Clin North Am 2005; 17(4):467-73.
44. Pedersen TK, Gronhøj J, Melsen B, Herlin T. Condylar condition and mandibular growth during early functional treatment of children with juvenile chronic arthritis. Eur J Orthod 1995; 17(5):385-94.